KPV stands for lysine–proline–valine, a three-residue peptide sequence. The supplied certificate prints KPV, but does not specify the terminal groups in that sequence line. Those details matter when identifying the complete chemical form.
Read KPV as a sequence
The existing primary identity sources describe KPV as Lys-Pro-Val. The supplied 10 mg report also prints KPV and calls the material a synthetic tripeptide. These records support the residue order; the report’s abbreviated notation does not supply every structural field.Dalmasso et al. (2008) (opens in a new tab)KPV 10 mg report: MA-KPV-0012 (opens in a new tab)
| Field | Reference or document detail |
|---|---|
| Name and sequence shorthand | KPV; Lys-Pro-Val; lysine–proline–valine |
| Residues | 3 |
| Sequence in the supplied report | KPV |
| Terminal groups | Not specified in the report’s sequence line |
| CAS number | 67727-97-3 (PubChem registry number for the Lys-Pro-Val tripeptide); not verified for the supplied form, whose terminal groups the report does not state |
| Molecular formula and weight | Not assigned here because the complete terminal and material form is unresolved |
Keep variant notation visible
Elliott and colleagues’ material descriptions distinguish KPV from KP-D-V, which explicitly changes the valine stereochemical designation. Keep the D notation when recording that variant rather than shortening both descriptions to KPV.Elliott et al. (2004), PMID 15102092 (opens in a new tab)
The report itself records identity matching against a qualified reference by LC-HRMS. Request the reference’s full sequence notation, terminal groups and chemical form when a complete identity specification is needed. This is more precise than filling the empty fields from a similarly named listing.KPV 10 mg report: MA-KPV-0012 (opens in a new tab)
Connect the sequence to the sample record
The linked 10 mg certificate is report MA-KPV-0012, revision 01, for lot KPV-12-PR5. It separates the identity result, chromatographic area percentage and measured content. Its reported content is 9.99 mg; that result belongs to the named sample.KPV 10 mg report: MA-KPV-0012 (opens in a new tab)
For a blend containing KPV, retain KPV as its own component with its own amount and identity reference. The KLOW guide provides the documented four-component declaration.KPV 10 mg report: MA-KPV-0012 (opens in a new tab)KLOW 80 mg report: MA-BLD-0010 (opens in a new tab)
Product and certificate checks
Sources and further detail
- KPV 10 mg report: MA-KPV-0012 (opens in a new tab)
Supplied PDF re-read on 3 October 2026. Identity wording and document-specific results are transcribed; this is not independent authentication.
- Dalmasso et al. (2008) (opens in a new tab)
Existing dossier used only for the Lys-Pro-Val identity notation.
- Elliott et al. (2004), PMID 15102092 (opens in a new tab)
Existing material-description evidence for KPV and the explicitly named D-valine variant.
- KLOW 80 mg report: MA-BLD-0010 (opens in a new tab)
Supplied PDF re-read on 3 October 2026. Identity wording and document-specific results are transcribed; this is not independent authentication.
Revised 3 October 2026 using the existing source dossier and the specified primary identity records. Report values describe the linked samples. Products are for laboratory research use only.